The invention relates to a device for the optimal organ-tolerable sealing, with minimal irritation, of bodily orifices, said device consisting of an extremely thin-walled, externally fillable balloon body having a central tube piece connecting the interior of the intestine to the perianal region of the anus, the tube piece being made of a soft-film-type material with a low volumetric expandability, wherein in a preferred design, one end of the balloon, which during the production process is completely formed to its required final dimensions, is reverse folded through the other end, and both balloon ends are tight-fittingly interconnected in the region of the outer bodily orifice and a thin-walled, adhesive-coated soft-film proximally adjoins the connection region of the two balloon ends, allowing direct fixation of the device to the skin and thus completely eliminating rigid, potentially irritating components in the region of the anal canal and in the perianal region.

An eye treatment device, in particular for use in glaucoma therapy, comprising a least one applicator head for applying laser light (L) into the eye, said applicator head comprising at least one light guide having an exit end for the laser light (L) and a cavity having an opening enclosed by a contact ring for placement on the eye, said light guide extending self-supporting and/or exposed within the cavity.

Methods of selecting and implanting prosthetic devices for use as a replacement meniscus are disclosed. The selection methods include a pre-implantation selection method and a during-implantation selection method. The pre-implantation selection method includes a direct geometrical matching process, a correlation parameters-based matching process, and a finite element-based matching process. The implant identified by the pre-implantation selection method is then confirmed to be a suitable implant in the during-implantation selection method. Methods of implanting meniscus prosthetic devices are also disclosed.

Various embodiments relate to a stent assembly comprising a stent; a swellable coating disposed on at least a portion of an exterior surface of the stent; optionally, a carrier dispersed in the swellable coating and/or disposed on at least a portion of an exterior surface of the stent; and an active agent comprised in at least one of the swellable coating or the carrier, if present. Use of the stent assembly as a ureteric stent, and method of preparing a stent assembly are also provided.

The present invention provides a method for stabilizing a fractured bone. The method includes positioning an elongate rod in the medullary canal of the fractured bone and forming a passageway through the cortex of the bone. The passageway extends from the exterior surface of the bone to the medullary canal of the bone. The method also includes creating a bonding region on the elongate rod. The bonding region is generally aligned with the passageway of the cortex. Furthermore, the method includes positioning a fastener in the passageway of the cortex and on the bonding region of the elongate rod and thermally bonding the fastener to the bonding region of the elongate rod while the fastener is positioned in the passageway of the cortex.

An intraocular lens (IOL) having an optical axis extending in an anterior-posterior direction and an equator extending in a plane substantially perpendicular to the optical axis is described. The IOL includes: an elastic anterior face located anterior to the equator; a posterior face located posterior to the equator, wherein the anterior face, the posterior face, or both comprises a poly(dimethylsiloxane) elastomer having a durometer between about 20 Shore A to about 50 Shore A; and a chamber located between the anterior face and the posterior face comprising a silicone oil comprising polysiloxanes comprising diphenyl siloxane and dimethyl siloxane units, the silicone oil having a maximum viscosity of about 800 cSt at 25° C.

Embodiments include prosthetic valves and related methods. In an embodiment, an implantable valve is included having a frame that includes a plurality of frame struts. The frame can define a central lumen. An outer skirt can be disposed on an abluminal surface of the frame. The outer skirt can include a flap having a first end and a second end. The first end of the flap can be fixed to the abluminal surface of the frame and the second end can be free to move away from the abluminal surface of the frame. Other embodiments are also included herein.

The invention primarily relates to fastening and stabilizing tissues, implants, and/or bondable materials, such as the fastening of a tissue and/or implant to a bondable material, the fastening of an implant to tissue, and/or the fastening of an implant to another implant. This may involve using an energy source to bond and/or mechanically to stabilize a tissue, an implant, a bondable material, and/or other biocompatible material. The invention may also relate to the use of an energy source to remove and/or install an implant and/or bondable material or to facilitate solidification and/or polymerization of bondable material.

A fluid dispensing device includes a cartridge comprising a housing and a head coupled to the housing. The housing forms a first chamber configured to accommodate a fluid; and the head includes a nozzle; and an elastomeric wall that is spaced from the nozzle to form a holding chamber. The holding chamber is in fluid communication with the first chamber and configured to accommodate a portion of the fluid; and the nozzle forms one or more openings to eject the portion of the fluid from the holding chamber. The one or more openings form an oblong shape such that a length of the oblong shape is greater than a width of the oblong shape. The one or more openings can include two parallel slots that together form the oblong shape.

Described herein is an ocular implant system in which an implant (200) is deployed in a posterior space of the eye, for example, the suprachoroidal space or the subconjunctival space or the intrascleral space, with an access within the anterior chamber (160) for reducing intraocular pressure therein. The shunt (200) is implanted using an implantation device comprising a hollow shaft (330) mounted over a fixed shaft (320). The shunt (200) is located in a distal end of the hollow shaft (330) and adjacent a distal end of the fixed shaft (320), the distal end of the fixed shaft being located at a position behind the distal end of the hollow shaft. Once the distal end of the hollow shaft (330) with the shunt (200) is located at the desired depth within the posterior space, the hollow shaft is withdrawn over the fixed shaft towards the proximal end thereof to leave the shunt in the posterior space with an access within the anterior chamber (160).